Compare Stocks → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AMYTCVE:BMKNYSEARCA:EPICVE:ICCNYSEARCA:PBP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMYTAmryt Pharma$14.70+0.1%$14.64$6.41▼$14.77$940.21M0.84757,360 shs2.39 million shsBMKMacDonald Mines ExplorationC$0.05-9.1%C$0.05C$0.03▼C$0.09C$1.89M0.4861,967 shs103,430 shsEPIWisdomTree India Earnings Fund$43.56+0.9%$43.36$31.10▼$45.02$1.26B0.721.17 million shs702,982 shsICCICC LabsC$1.62-5.8%C$1.62C$0.87▼C$2.00C$223.64MN/A799,310 shs646,156 shsPBPInvesco S&P 500 BuyWrite ETF$22.48+0.5%$22.09$20.63▼$22.51$100.04M0.6414,534 shs42,076 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMYTAmryt Pharma0.00%0.00%0.00%0.00%+0.82%BMKMacDonald Mines Exploration-9.09%0.00%0.00%-16.67%-28.57%EPIWisdomTree India Earnings Fund+0.93%+1.93%-1.49%+6.24%+39.53%ICCICC Labs0.00%0.00%0.00%0.00%0.00%PBPInvesco S&P 500 BuyWrite ETF+0.54%+0.40%+1.72%+3.59%+6.36%Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMYTAmryt PharmaN/AN/AN/AN/AN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/AN/AN/AN/AN/AN/AN/AN/AEPIWisdomTree India Earnings FundN/AN/AN/AN/AN/AN/AN/AN/AICCICC LabsN/AN/AN/AN/AN/AN/AN/AN/APBPInvesco S&P 500 BuyWrite ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMYTAmryt PharmaN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/AN/AN/AN/AEPIWisdomTree India Earnings Fund0.00N/AN/AN/AICCICC LabsN/AN/AN/AN/APBPInvesco S&P 500 BuyWrite ETF0.00N/A$23.785.80% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMYTAmryt Pharma$222.54M4.22$0.98 per share14.98$5.58 per share2.63BMKMacDonald Mines ExplorationC$-74K-25.59C$0.00 per share13.00C($0.01) per share-5.00EPIWisdomTree India Earnings FundN/AN/AN/AN/AN/AN/AICCICC LabsC$533.68K419.04C$0.06 per share28.42C$0.29 per share5.68PBPInvesco S&P 500 BuyWrite ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMYTAmryt Pharma$1M-$0.06N/A735.00N/A-8.19%1.70%0.75%N/ABMKMacDonald Mines Exploration-C$1.28M-C$0.02N/A∞N/AN/A-1,679.48%-324.12%5/6/2024 (Estimated)EPIWisdomTree India Earnings FundN/AN/A9.65∞N/AN/AN/AN/AN/AICCICC LabsN/AC$0.0295.29∞N/AN/AN/AN/AN/APBPInvesco S&P 500 BuyWrite ETFN/AN/A18.44∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMYTAmryt PharmaN/AN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/AN/AN/AN/AN/AEPIWisdomTree India Earnings Fund$1.964.50%N/AN/AN/AICCICC LabsN/AN/AN/AN/AN/APBPInvesco S&P 500 BuyWrite ETF$0.271.20%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMYTAmryt Pharma0.641.570.94BMKMacDonald Mines Exploration3.840.220.27EPIWisdomTree India Earnings FundN/AN/AN/AICCICC LabsN/A24.848.74PBPInvesco S&P 500 BuyWrite ETFN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMYTAmryt Pharma71.31%BMKMacDonald Mines Exploration1.10%EPIWisdomTree India Earnings FundN/AICCICC LabsN/APBPInvesco S&P 500 BuyWrite ETFN/AInsider OwnershipCompanyInsider OwnershipAMYTAmryt Pharma5.66%BMKMacDonald Mines Exploration8.53%EPIWisdomTree India Earnings FundN/AICCICC LabsN/APBPInvesco S&P 500 BuyWrite ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAMYTAmryt Pharma2,02063.96 million60.34 millionNot OptionableBMKMacDonald Mines Exploration237.88 millionN/ANot OptionableEPIWisdomTree India Earnings FundN/A29.00 millionN/ANot OptionableICCICC LabsN/A138.05 millionN/ANot OptionablePBPInvesco S&P 500 BuyWrite ETFN/A4.45 millionN/ANot OptionableBMK, AMYT, ICC, EPI, and PBP HeadlinesSourceHeadlineInvesco 500 BuyWrite ETF declares quarterly distribution of $0.1751msn.com - March 19 at 1:15 PMInvesco S&P 500 ex-Rate Sensitive Low Volatility ETF declares monthly distribution of $0.0940msn.com - February 20 at 9:00 AMS&P 500 Inches Higher, Small-Cap Rally Stalls, Bitcoin Sinks: What's Driving Markets Thursday?markets.businessinsider.com - December 28 at 2:41 PMInvesco 500 Pure Value ETF declares quarterly distribution of $0.5008msn.com - December 20 at 2:19 PMInvesco 500 High Beta ETF declares quarterly distribution of $0.1693msn.com - December 20 at 2:19 PMInvesco S&P 500 Equal Weight Real Estate ETFwsj.com - August 5 at 2:18 AMS&P 500 to Fall by 64%? Low-Volatility ETFs in Focusmsn.com - July 28 at 2:13 PMInvesco S&P 500 ex-Rate Sensitive Low Volatility ETF declares monthly distribution of $0.1080msn.com - July 24 at 5:10 PMRYF Invesco S&P 500® Equal Weight Financials ETFseekingalpha.com - July 21 at 6:24 PMSPY and QQQ ETFs are Buzzing on Reddit: Is There More Upside Left?markets.businessinsider.com - July 19 at 12:18 PMIs Invesco S&P 500 Equal Weight Industrials ETF (RSPN) a Strong ETF Right Now?msn.com - June 29 at 8:15 AMIs Invesco S&P 500 Equal Weight Technology ETF (RSPT) a Strong ETF Right Now?msn.com - June 27 at 8:22 AMHow the price action of Invesco S&p 500 Buywrite ($PBP) is used to our Advantagemarketwatch.com - May 8 at 12:48 AMThis twist on a traditional S&P 500 stock fund can lower your risk and still beat the market overallmsn.com - April 25 at 8:41 PMWednesday's ETF with Unusual Volume: PBPnasdaq.com - April 19 at 4:05 PMCould This Alternative S&P 500 Index ETF Make You More Money Than the Most Popular ETFs?fool.com - April 5 at 6:38 AMInvesco S&P 500® Equal Wt Indls ETFmoney.usnews.com - February 24 at 5:07 PMInvesco S&P 500 Low Volatility ETF declares monthly distribution of $0.1194msn.com - February 20 at 1:24 PMInvesco S&P 500 ex-Rate Sensitive Low Volatility ETF declares monthly distribution of $0.0853msn.com - February 20 at 1:24 PMInvesco 500 BuyWrite ETF declares quarterly distribution of $0.0649msn.com - December 22 at 4:38 PMAnalysts Predict 27% Upside For PBPnasdaq.com - September 23 at 2:27 PMInvesco Markets III Plc S&P 500 QVM UCITS ETF (GBP) (PQVG)hl.co.uk - September 14 at 7:31 PMInvesco S&P 500 BuyWrite ETF Newsthestreet.com - July 13 at 8:20 PMRPV: Pure Value Is Outpacing The S&P 500 This Year, Can It Continue?seekingalpha.com - June 6 at 12:36 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Ways5 Under-the-Radar Artificial Intelligence (AI) Stocks March 4, 2024 9:30 AMView 5 Under-the-Radar Artificial Intelligence (AI) Stocks Your Comprehensive Guide to Investing in Bank StocksMarch 1, 2024 10:41 AMView Your Comprehensive Guide to Investing in Bank StocksWorkday Stock Price is Working on a Buy-the-Dip OpportunityFebruary 28, 2024 7:10 AMView Workday Stock Price is Working on a Buy-the-Dip OpportunityFoot Locker Stock Is the Retail Value Play Growing at 46%March 5, 2024 6:15 AMView Foot Locker Stock Is the Retail Value Play Growing at 46%All Headlines Company DescriptionsAmryt PharmaNASDAQ:AMYTAmryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.MacDonald Mines ExplorationCVE:BMKMacDonald Mines Exploration Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for gold, silver, copper, cobalt, and nickel deposits. It owns 100% interest in the Scadding-Powerline-Jovan property that covers an area of 19,710 hectares located to the east of Sudbury in Northern Ontario. The company was formerly known as MacDonald Mines Limited. MacDonald Mines Exploration Ltd. was incorporated in 1936 and is based in Toronto, Canada.WisdomTree India Earnings FundNYSEARCA:EPIWisdomTree India Earnings Fund (The Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree India Earnings Index. The Index measures the performance of profitable companies incorporated and traded in India that are eligible to be purchased by foreign investors and that meet specific criteria developed by WisdomTree Investments.ICC LabsCVE:ICCICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.Invesco S&P 500 BuyWrite ETFNYSEARCA:PBPThe Invesco S&P 500 BuyWrite ETF (PBP) is an exchange-traded fund that is based on the Cboe S&P 500 BuyWrite index. The fund tracks an index that uses a covered-call strategy to provide long exposure to the S&P 500 and selling call options thereon. PBP was launched on Dec 20, 2007 and is managed by Invesco. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.